PUNE, India, October 25, 2017 /PRNewswire/ --

The global digital pathology market size will reach $756.1 million by 2022 from $423.1 million in 2017 at a CAGR of 12.3% during (2017-2022) driven by rising prevalence of cancer, increasing adoption of digital pathology to enhance lab efficiency, increasing initiatives by governments & industry players, ease of consultation, and growing applications of digital pathology in drug development and companion diagnostics according to ReportsnReports.com.

Browse 85 Market Data Tables and 33 Figures spread through 154 Pages and in-depth TOC on "Digital Pathology Market by Product (Scanner, Software, Communication System), Type (Human, Veterinary), Application (Teleconsultation, Disease Diagnosis, Drug Discovery), End User (Pharmaceutical & Biotechnology Companies) - Global Forecast to 2022" http://www.reportsnreports.com/reports/195916-digital-pathology-market-slide-scanners-whole-slide-imaging-analytics-image-analysis-software-delivery-modes-web-based-cloud-based-and-whole-slide-image-storage-global-trends-forecast-till-2017.html .

North America to dominate the digital pathology market and APAC projected to grow at the highest CAGR during the forecast period. The North America is expected to hold the largest share of the global digital pathology market in 2017. The large share of this region can be attributed to factors such as the rising prevalence of chronic diseases and increasing initiatives by industry players and governments in diagnostics. However, Asia Pacific is expected to grow at the highest CAGR during the forecast period. Factors such as large patient population, shortage of pathologists, increasing initiatives in the healthcare industry by key market players, and rising adoption of advanced technologies for disease diagnosis are driving the growth of the digital pathology market in this region.

The major players in the global digital pathology market are Leica Biosystems (Germany), Ventana Medical Systems (US), and Hamamatsu Photonics (Japan). Other players include 3DHISTECH (Hungary), Philips (Netherlands), Apollo Enterprise Imaging (US), XIFIN (US), Visiopharm (Denmark), Corista (US), Huron Digital Pathology (Canada), Objective Pathology Services (Canada), and Indica Labs (US).

Make an Inquiry on "Digital Pathology Market - Global Forecast to 2022" research report at http://www.reportsnreports.com/contacts/inquirybeforebuy.aspx?name=195916 .

On the basis of end user, the digital pathology market is classified into pharmaceutical and biotechnology companies, hospitals and reference laboratories, and academic & research institutes. The pharmaceutical and biotechnology companies segment is estimated to account for the largest share of the digital pathology market. Factors contributing to the large share and high growth rate of this segment include the increasing use of digital pathology for drug discovery studies and drug toxicology testing. Biotechnology companies also use digital pathology for bio banking, biopharmaceutical studies, and molecular assays.

The software segment account largest share of the digital pathology market. By product, the digital pathology market is segmented into scanners, software, communication systems, and storage systems. The scanners segment is estimated to account for the largest share of the global digital pathology market in 2017. The large share of this segment is mainly due to the increasing adoption of digital pathology solutions across the globe.

Inquire for Discount on "Digital Pathology Market - Global Forecast to 2022" research report at http://www.reportsnreports.com/contacts/discount.aspx?name=195916 .

The report analyzes the digital pathology market and aims at estimating the market size and the future growth potential of this market based on various segments such as product, type, application, end user, and region. The report also includes an in-depth regulatory analysis for various regions across the globe and competitive analysis of the key players in this market along with their company profiles, product offerings, recent developments, and key market strategies.

Break of primary participants was as mentioned below:

• By Company Type: Tier 1: 56%, Tier 2: 35%, and Tier 3: 9%
• By Designation: C-level: 27%, Director Level: 15%, Others: 58%
• By Region: North America: 45%, Europe: 29%, Asia-Pacific: 20%, RoW: 6%

Another research titled Patient Registry Software Market Global Forecast to 2022 says, the global patient registry software market is expected to reach $1,429.1 million by 2022 from $807.4 million in 2017, at a CAGR of 12.1%. The disease registries segment is expected to grow at the highest CAGR. Population health management segment to dominate the global patient registry software market in 2017. Asia-Pacific to witness the highest CAGR during the forecast period. Companies such as Phytel, Inc. (An IBM Company), QUINTILES IMS HOLDINGS, INC., Liaison Technologies., ImageTrend Inc., FIGmd Inc., McKesson Corporation, CECity.com Inc. (A Premier, Inc. Company), Dacima Software Inc., Global Vision Technologies Inc., ifa systems AG, INC RESEARCH HOLDINGS INC., M2S (Medstreaming Company), Optum Inc (a part of UnitedHealth Group Incorporated), EVADO Pty. Ltd., Velos Inc. have been profiled in this 317 pages research report available at http://www.reportsnreports.com/reports/323192-patient-registry-software-market-by-delivery-mode-subscription-ownership-functionality-population-health-management-point-of-care-care-management-database-diabetes-cancer-cardiovascular-chronic-rare-disease-by-end-user-forecast-to-2019.html .

Explore more reports on Healthcare Market at http://www.reportsnreports.com/market-research/healthcare/ .

About Us: 

ReportsnReports.com is an online market research reports library of 500,000+ in-depth studies of over 5000 micro markets. Not limited to any one industry, ReportsnReports.com offers research studies on agriculture, energy and power, chemicals, environment, medical devices, healthcare, food and beverages, water, advanced materials and much more.

Contact:
Hrishikesh Patwardhan
2^nd Floor, Metropole Building,
Next to Inox Theatre,
Bund Garden Road, Pune - 411001.
Maharashtra, India.
+1-888-391-5441
sales@reportsandreports.com

Connect with Us:

LinkedIn: http://www.linkedin.com/company/reportsnreports

RSS/Feeds: http://www.reportsnreports.com/feed/l-latestreports.xml

SOURCE ReportsnReports